Products for Research Use Only

DSPE-PEG-NHS, MW 2000

CAT: 0804-HY-W441014-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W441014-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DSPE-PEG-NHS, MW 2000 is a PEG-modified phospholipid derivative that can be used to prepare liposomes. DSPE-PEG-NHS, MW 2000 is commonly employed as a linker molecule for the surface modification of liposomes to confer targeting capabilities. DSPE-PEG-NHS, MW 2000 can be used in the study of drug delivery[1][2].
UNSPSC
12352211
Hazard Statement
H302, H315, H319, H335
Target
Liposome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/dspe-peg-nhs-mw-2000.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCCCCCCCCCCCCCC(OC[C@@H](OC(CCCCCCCCCCCCCCCCC)=O)COP(OCCNC(OCCNC(CCC(ON1C(CCC1=O)=O)=O)=O)=O)(O)=O)=O.[n]
Molecular Weight
2000 (Average)
Precautions
H302, H315, H319, H335
References & Citations
[1]Zhang X, et al. The study on brain targeting of the amphotericin B liposomes. J Drug Target. 2003 Feb;11 (2) :117-22.|[2]Zhao W, et al. DSPE-PEG Modification of α-Conotoxin TxID. Mar Drugs. 2019 Jun 8;17 (6) :342.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported